Saudi German Health (SGH) has signed a Memorandum of Understanding (MoU) with Becton, Dickinson and Company (BD), a...
A research team led by Professor Kevin Tsia, programme director of the Biomedical Engineering Programme under the Facult...
Harrison.ai, a leading global healthtech company and developer of artificial intelligence (AI)-powered medical diagnosti...
The Hong Kong Polytechnic University (PolyU) and Shandong First Medical University (SDFMU) have signed a Memorandum of U...
Gene Solutions (GS), a pioneer genomic testing company in South-East Asia, aims to introduce a smart blood test to ...
Hikma Pharmaceuticals PLC, a British pharmaceutical group, has signed a strategic memorandum of understanding (MoU) with...
Nanyang Technological University, Singapore (NTU Singapore) spin-off company Gray Matter Solutions is partnering w...
Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, ha...
US-based Guardant Health, Inc., a leading precision oncology company, has announced an agreement with the Abu Dhabi Publ...
The global medtech market, valued at an impressive $640 billion, is on track to surpass $960 billion by 2030 growing at ...
Cancer is inherently diverse, with significant variations both between different tumours and among individuals. This var...
The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approxi...
Research has shown the potential for artificial intelligence (AI) to assist in the diagnosis of conditions, like endomet...
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, has announced that the US Food and Drug Administra...
Expecto Health Science, a leading full-service Contract Research Organization (CRO) in Asia Pacific with a focus on emer...
Datar Cancer Genetics (DCG), with research facilities in India, US and the UK, has announced the launch of Target-MRD, a...
Taiwan-based Advanced Genomics APAC Co. has announced the signing of an exclusive service provider agreement with Cancer...
The World Health Organization (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6...
